Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 73,000
+4,100 (5.95%)
Sep 1, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 449.06 billion as of September 1, 2026. Its market cap has decreased by -46.29% in one year.
Market Cap
449.06B
Enterprise Value
530.61B
Revenue
251.08B
Ranking
n/a
PE Ratio
30.79
Stock Price
73,000.00
ChartMarket Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 449.06B, an increase of 526.08%. That is a compound annual growth rate of 10.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 475.78B | -43.89% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Komipharm International | 673.50B |
| Pharmicell | 673.25B |
| Onconic Therapeutics | 670.67B |
| Hyundai Bioscience | 634.99B |
| GI Innovation | 521.93B |
| AbClon | 490.82B |
| GC Corp. | 455.38B |
| Proteina | 396.16B |